Clinical Trial: Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: First Progression of Glioblastoma
Study Type: INTERVENTIONAL
Official Title: Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
Brief Summary:
Despite comprehensive multimodal treatment of newly diagnosed glioblastoma, almost all patients suffer from tumour relapse.Currently, no standard of care exists to treat these tumour relapses.Treatment options include repeated surgery (if feasible), systemic therapy (bevacizumab, lomustine, temozolomide re-challenge), reirradiation and best supportive care.Currently, the superiority of combined chemoradiation versus chemotherapy alone remains unproven.Given that lomustine is the standard chemotherapeutic agent for…
Read more